Infinion Biopharma Limited is a public company, founded on 16 Jan 2018. This company focuses on innovation that blends biophysics, engineering, classical pharmacology, and biochemistry to generate high-value products across a range of therapeutic areas. A total of 45 lakh equity shares with a face value of Rs. 10 will be sold as part of the Initial public offering.

Purpose of the Issue

  • To meet working capital requirement
  • Using this fund to invest in Mobius Biomedical Inc.
  • Acquire licenses in women’s health products and skin care for product development

 

Infinion Biopharma Ltd. Financial details

Particulars

 (in Rs.crores)

FY21

FY20

FY19

Total Assets

18.30

8.69

7.58

Share Capital

10.45

9.99

7.55

Total Borrowings

0.00

0.30

0.37

Profit After Tax

64,240.27

13,697.46

3,635.15

 

IPO Details

IPO Open and Close Date

To be announced

Listing At

NSE, BSE

Allotment Date

To be announced

IPO Listing Date

To be announced

Initiation of Refunds

To be announced

The credit of shares to Demat Account

To be announced

 

Leave a Reply

Your email address will not be published. Required fields are marked *